Treatment options

A challenge in providing appropriate care for women with breast cancer is the rapid expansion of new treatments. The rate at which information emerges about new treatments presents a challenge for keeping clinical practice guidelines and consumer information up to date. There is a need for current evidence-based information about new treatments to support the information needs of women with breast cancer, clinicians, media and policy-makers.

In 2003 the National Breast Cancer Centre* commissioned two systematic reviews of new treatments for breast cancer:

• Use of luteinising hormone-releasing hormone agonists for adjuvant treatment of early breast cancer

  • Summary report; (pdf 122kb)

  • Full report (pdf 304kb)

• Use of taxanes for adjuvant and neo-adjuvant treatment of early and locally advanced breast cancer

  • Summary report (pdf 118kb)

  • Full report (pdf 305kb)

* In February 2008, National Breast Cancer Centre (NBCC) changed its name to National Breast and Ovarian Cancer Centre (NBOCC).

 

Print preview

National Directory of Hospital Based Services

Tell us more »
	Was this site useful/helpful?
very  quite  uncertain  not
	Did you find the information you were looking for?
yes  partly  uncertain  no
	What were you looking for?